Humoral immune response and lymphocyte levels after complete vaccination against COVID-19 in a cohort of multiple sclerosis patients treated with cladribine tablets

por Christoph Grothe, Falk Steffen, Stefan Bittner
Publicado 2021

Adjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of Parkinson’s disease

por Hua-Ying Cai, Xiao-Xiao Fu, Hong Jiang, Shu Han
Publicado 2021

Exploring human-genome gut-microbiome interaction in Parkinson’s disease

por Zachary D. Wallen, William J. Stone, Stewart A. Factor, Eric Molho, Cyrus P. Zabetian, David G. Standaert, Haydeh Payami
Publicado 2021

Prognostic biomarkers of Parkinson’s disease in the Spanish EPIC cohort: a multiplatform metabolomics approach

por Carolina Gonzalez-Riano, Jorge Saiz, Coral Barbas, Alberto Bergareche, José Mª Huerta, Eva Ardanaz, Marcela Konjevod, Elisabet Mondragon, M. E. Erro, M. Dolores Chirlaque, Eunate Abilleira, Fernando Goñi-Irigoyen, Pilar Amiano
Publicado 2021

Parkinson’s disease patients benefit from bicycling - a systematic review and meta-analysis

por Marianne Tiihonen, Britta U. Westner, Markus Butz, Sarang S. Dalal
Publicado 2021

Author Correction: TNFα increases tyrosine hydroxylase expression in human monocytes

por Adithya Gopinath, Martin Badov, Madison Francis, Gerry Shaw, Anthony Collins, Douglas R. Miller, Carissa A. Hansen, Phillip Mackie, Malú Gámez Tansey, Abeer Dagra, Irina Madorsky, Adolfo Ramirez-Zamora, Michael S. Okun, Wolfgang J. Streit, Habibeh Khoshbouei
Publicado 2021

Technology-based therapy-response and prognostic biomarkers in a prospective study of a de novo Parkinson’s disease cohort

por Giulia Di Lazzaro, Mariachiara Ricci, Giovanni Saggio, Giovanni Costantini, Tommaso Schirinzi, Mohammad Alwardat, Luca Pietrosanti, Martina Patera, Simona Scalise, Franco Giannini, Antonio Pisani
Publicado 2021

TOMM40 ‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s disease

por Megan C. Bakeberg, Anastazja M. Gorecki, Abigail L. Pfaff, Madison E. Hoes, Sulev Kõks, P. Anthony Akkari, Frank L. Mastaglia, Ryan S. Anderton
Publicado 2021

Longitudinal evolution of non-motor symptoms in early Parkinson’s disease: a 3-year prospective cohort study

por Ruwei Ou, Yanbing Hou, Qianqian Wei, Junyu Lin, Kuncheng Liu, Lingyu Zhang, Zheng Jiang, Bei Cao, Bi Zhao, Wei Song, Huifang Shang
Publicado 2021

A real-world study of wearable sensors in Parkinson’s disease

por Jamie L. Adams, Karthik Dinesh, Christopher W. Snyder, Mulin Xiong, Christopher G. Tarolli, Saloni Sharma, E. Ray Dorsey, Gaurav Sharma
Publicado 2021

Transcriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels

por Rubén Fernández-Santiago, Anna Esteve-Codina, Manel Fernández, Francesc Valldeoriola, Almudena Sanchez-Gómez, Esteban Muñoz, Yaroslau Compta, Eduardo Tolosa, Mario Ezquerra, María J. Martí
Publicado 2021

Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis

por J. M. Hatcher-Martin, J. L. McKay, A. F. Pybus, B. Sommerfeld, J. C. Howell, F. C. Goldstein, L. Wood, W. T. Hu, S. A. Factor
Publicado 2021

Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson’s disease

por Francesc Valldeoriola, María José Catalán, Francisco Escamilla-Sevilla, Eric Freire, Jesús Olivares, Esther Cubo, Diego Santos García, Matilde Calopa, Pablo Martínez-Martín, Juan Carlos Parra, Gloria Arroyo, José Matías Arbelo
Publicado 2021

Microdialysis and microperfusion electrodes in neurologic disease monitoring

por Luke A. Stangler, Abbas Kouzani, Kevin E. Bennet, Ludovic Dumee, Michael Berk, Gregory A. Worrell, Steven Steele, Terence C. Burns, Charles L. Howe
Publicado 2021

Precision antiplatelet therapy for the prevention of ischaemic stroke

por David Wang

Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach

por Tainá M. Marques, Anouke van Rumund, Iris Kersten, Ilona B. Bruinsma, Hans J.C.T. Wessels, Jolein Gloerich, Charlotte Kaffa, Rianne A. J. Esselink, Bastiaan R. Bloem, H. Bea Kuiperij, Marcel M. Verbeek
Publicado 2021

A transcriptome-wide association study identifies susceptibility genes for Parkinson’s disease

por Shi Yao, Xi Zhang, Shu-Cheng Zou, Yong Zhu, Bo Li, Wei-Ping Kuang, Yan Guo, Xiao-Song Li, Liang Li, Xiao-Ye Wang
Publicado 2021

Subthalamic and pallidal deep brain stimulation for Parkinson’s disease—meta-analysis of outcomes

por M. Lenard Lachenmayer, Melina Mürset, Nicolas Antih, Ines Debove, Julia Muellner, Maëlys Bompart, Janine-Ai Schlaeppi, Andreas Nowacki, Hana You, Joan P. Michelis, Alain Dransart, Claudio Pollo, Guenther Deuschl, Paul Krack
Publicado 2021

Lateralized effects of deep brain stimulation in Parkinson’s disease: evidence and controversies

por Zhengyu Lin, Chencheng Zhang, Dianyou Li, Bomin Sun
Publicado 2021

A randomised controlled trial on effectiveness and feasibility of sport climbing in Parkinson’s disease

por Agnes Langer, Sebastian Hasenauer, Anna Flotz, Lucia Gassner, Rochus Pokan, Peter Dabnichki, Laurenz Wizany, Jakob Gruber, Dominik Roth, Sarah Zimmel, Marco Treven, Michaela Schmoeger, Ulrike Willinger, Walter Maetzler, Heidemarie Zach
Publicado 2021